Q&A: How Health Care Providers Can Help Increase COVID-19 Vaccine Uptake
Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around the importance of COVID-19 vaccines.
FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency
Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.
Diabetes Roundup: FDA Clears Omnipod 5, Tirzepatide Demonstrates Trial Success, and More
Catch up on important diabetes news from the month of August.
FDA Roundup: Agency Highlights from August 2024
Checkout these important FDA updates from the month of August 2024.
Roflumilast Cream Shows Durable Safety, Efficacy in Children with Atopic Dermatitis
Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.
Q&A: Opill Ushers in New Era of Access to Birth Control
Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.
Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use
As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.
Investigational Acute Pain Therapy to be Evaluated in Pivotal Phase 3 Trials
Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.
Drug Topics Top 10: Most Read Stories From August 2024
Check out this list of our top 10 stories from August 2024.
School Openings After COVID-19 Lockdowns Associated With Increased Psychiatric Emergencies
Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.
Free At-Home COVID-19 Test Program Returns as Cases Rise
The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”
In Depth Perspectives: Importance of Patient Advocacy, PBM Scrutiny, and More
Check out these top featured stories from Drug Topics in August 2024.
Dexcom’s OTC Continuous Glucose Monitor Now Available in US
The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.
High-Dose, Adjuvanted Flu Vaccines Prove More Effective for Older Adults
“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.
Voices in Pharmacy: August 2024 Expert Interviews
Check out these featured Drug Topics interviews from August 2024.
Weekend ICYMI: August 19 to August 23
In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.
Small Doses: August 19 to August 23
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Pharmacy Deserts Prominent in Areas of High Social Vulnerability
Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.
FDA Roundup: Updated COVID-19 Vaccines, Treprostinil for PAH Associated With PH-ILD
Check out important updates from the FDA for the week of August 19.
Q&A: The Importance of Cooling Technology for Prescription Drugs
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.
Disparities Hinder HPV Vaccine Goals in USAPI Jurisdictions
Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.
Q&A: How Phononic is Revolutionizing Heating and Cooling for Pharmaceuticals
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the role his company’s technology plays in the pharmaceutical industry.
Meat Consumption Linked with Higher Risk of Developing Type 2 Diabetes
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
Q&A: Discussing the Dangers of Buying GLP-1s From Online Pharmacies
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Majority of Savings from CMS Price Negotiations Comes From 3 Drugs
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
Amneal Pharmaceuticals Receives FDA Approval for Propofol Injectable Emulsion Single-Dose Vials
FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.
Otezla for Treatment of Pediatric Plaque Psoriasis Now Available in US
The approval of apremilast to treat plaque psoriasis in children and adolescents aged 6 years and older was based on data from the phase 3 SPROUT trial.
FDA Grants Tentative Approval to Treprostinil for PAH Associated With PH-ILD
Final approval of the therapy may occur after expiration of the 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025.
APhA Campaign Aims to Spread Awareness About Harmful PBM Practices
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
